Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study is using the combination of radiation and antiangiogenic agents (agents that
destroy existing blood vessels) seems to be an approach to tumor cure.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University